ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma.

Published in: Canadian journal of gastroenterology & hepatology (2022)

The expression of ARID1A could be used to predict the outcome of HCC. It is closely related to tumor immune cell infiltration.

Keyphrases